BioHarvest Sciences Inc. Common Stock
BHST · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $9 | $9 | $8 | $7 |
| % Growth | 6.5% | 8.3% | 8% | – |
| Cost of Goods Sold | $3 | $3 | $3 | $3 |
| Gross Profit | $6 | $5 | $5 | $4 |
| % Margin | 61.4% | 59.7% | 58.5% | 56.7% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $0 | $2 | $1 | $4 |
| SG&A Expenses | $5 | $6 | $5 | $4 |
| Sales & Mktg Exp. | $0 | $4 | $4 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $6 | $7 | $6 | $6 |
| Operating Income | -$1 | -$2 | -$2 | -$2 |
| % Margin | -10.1% | -21.3% | -21.9% | -23.2% |
| Other Income/Exp. Net | -$2 | -$2 | -$1 | -$1 |
| Pre-Tax Income | -$2 | -$4 | -$2 | -$3 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3 | -$4 | -$2 | -$3 |
| % Margin | -27.7% | -47.9% | -29.7% | -40.6% |
| EPS | -0.14 | -0.24 | -0.13 | -0.17 |
| % Growth | 41.7% | -84.6% | 23.5% | – |
| EPS Diluted | -0.14 | -0.24 | -0.13 | -0.17 |
| Weighted Avg Shares Out | 17 | 17 | 17 | 17 |
| Weighted Avg Shares Out Dil | 17 | 17 | 17 | 17 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $2 | $1 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$1 | -$1 | -$1 |
| % Margin | -5.9% | -16.5% | -16.8% | -18.5% |